top of page
Bioverativ Alprolix
The first two concepts are for Bioverativ's Alprolix, a cutting edge hemophilia drug used prophylactically and as needed. The idea behind these concepts were to show patients and doctors how Alprolix can be there to help prevent and control bleeding episodes so patients can live normal lives.
The last two concepts address "inhibitors" in hemophilia. Inhibitors prevent treatment efficacy for patients. In addition to prophylactic use, Alprolix also had a low inhibitor incidence. The options here demonstrate how both doctors and patients can lose their "inhibitions" to treat and live life respectively.
​
Writer: James Tarzian
Art Director: Hannah Clough
​
​
ALPROLIX HCP "READY" CONCEPT


1/1
ALPROLIX HCP "UNINHIBITED" CONCEPT


1/1
bottom of page